The goal of the Education and Information Transfer Core (EITC) in the University of Pennsylvania Alzheimer's Disease Center (ADC) is to improve how healthcare professionals, patients and caregivers understand and practice the standard of care for the diagnosis and treatment of patients with Alzheimer's disease (AD) and other neurodegenerative dementias. To achieve this goal, the EITC provides education and training to: 1) patients and their families who attend the Memory Disorders Clinic; 2) nurse practitioners; physician assistants; and residents and fellows in family medicine, neurology, internal medicine, and geriatrics; and 3) Spanish speaking patients and their caregivers. The EITC will continue its existing successful education and outreach programs and also expand its mission and skills in the following ways: 1) continue to provide up-to-date in-clinic and internet resource centers, 2) continue to provide state of the art training to healthcare professionals, 3) continue to provide an educational and outreach program in the Latino community in a joint initiative with the Alzheimer's Association of Greater Philadelphia and the Core B Clinica Latina Para Trastornos de la Memoria satellite clinic, and 4) 4) develop and implement interventions that assist patients and caregivers in making challenging ethical decisions about treatment and research. Wherever possible, we will collaborate with the local chapter of the Alzheimer's Association and disseminate successful products to other National Institute on Aging (NIA) funded ADCs and the NIA's ADEAR program.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
2P30AG010124-11
Application #
6494704
Study Section
Project Start
1991-09-30
Project End
2006-06-30
Budget Start
Budget End
Support Year
11
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Goldman, Jennifer G; Andrews, Howard; Amara, Amy et al. (2018) Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features. Mov Disord 33:282-288
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Jansen, Willemijn J; Ossenkoppele, Rik; Tijms, Betty M et al. (2018) Association of Cerebral Amyloid-? Aggregation With Cognitive Functioning in Persons Without Dementia. JAMA Psychiatry 75:84-95
Stites, Shana D; Rubright, Jonathan D; Karlawish, Jason (2018) What features of stigma do the public most commonly attribute to Alzheimer's disease dementia? Results of a survey of the U.S. general public. Alzheimers Dement 14:925-932
Seo, Sang Won; Thibodeau, Marie-Pierre; Perry, David C et al. (2018) Early vs late age at onset frontotemporal dementia and frontotemporal lobar degeneration. Neurology 90:e1047-e1056
Shi, Min; Tang, Lu; Toledo, Jon B et al. (2018) Cerebrospinal fluid ?-synuclein contributes to the differential diagnosis of Alzheimer's disease. Alzheimers Dement 14:1052-1062
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642
Zee, Jarcy; Xie, Sharon X (2018) The Kaplan-Meier Method for Estimating and Comparing Proportions in a Randomized Controlled Trial with Dropouts. Biostat Epidemiol 2:23-33

Showing the most recent 10 out of 720 publications